Aneeka Chatterjee
Aneeka Chatterjee
From processed food to multiple pregnancies, several factors behind their obesity
Biocon Biologics' own Insulin Aspart drug product for the US is currently under review by the US Food and Drug Administration (FDA)
Nigam shared details about the company's major project, set for completion by mid-September
A recent analysis by CRISIL Ratings of 91 private hospitals, which collectively generated approximately Rs 64,000 crore in revenue last financial year, supports this finding
The report underscored the challenges facing India's office market in 2024, attributing them to global macroeconomic uncertainty, escalating geopolitical tensions, and persistent inflation
BLR Airport, Menzies Aviation unveil India's largest DCT with 4 lakh MT capacity, ₹120 cr investment
Expedition matured for eight years in a specially sourced European Sherry cask, developing deep, opulent flavours
YESINTEK is approved for Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis, offering a cost-effective treatment for chronic autoimmune diseases
Beyond technology leaders, retailers in apparel, beauty, fashion, and entertainment are targeting Tier-II and -III cities, extending their reach beyond metro hubs
Jasoria highlighted that the brand aims to bridge the gap between pricing and aesthetics, focusing mainly on Gen Z
Growth driven by increasing volumes across modalities
The investment is expected to further enhance production capabilities by adding a new can, glass, and keg line
With younger buyers seeking more than just lavish homes, developers are curating the kind of homes they desire
Under the SWAMIH Fund, 50,000 dwelling units in stressed housing projects have been completed, and keys handed over to homebuyers
It also reported a profit before tax (PBT) of Rs 155.9 crore, down 80.8 per cent in Q3FY25
Net bookings in the real estate segment for Q3 FY25 stood at 2.19 million square feet, with a sale value of Rs 2,492 crore
India is poised to become the world's fourth-largest economy by 2026 and achieve the $5 trillion mark by 2028, according to the pre-Budget survey
In July 2023, Fidelity expanded its presence in India by opening its first office in Bengaluru, adding to existing locations in Gurugram and Mumbai
While firms like KPMG, Emkay Global, CRISIL, and Anarock see potential gains for overseas investors, they also caution about the challenges ahead if the rupee's fall continues
During the quarter, Discovery Services launched "China+1" pilots with large and mid-size pharma companies and converted them into long-term contracts. Growth signals stabilizing